LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
111.50
-2.80 (-2.45%)
Sep 10, 2026, 11:59 AM HKT
| Market Cap | 8.48B |
| Revenue (ttm) | 2.91M |
| Net Income | -249.58M |
| EPS | -4.04 |
| Shares Out | 74.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 137,800 |
| Open | 113.00 |
| Previous Close | 114.30 |
| Day's Range | 109.00 - 116.30 |
| 52-Week Range | 72.65 - 165.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |